| Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors A Egli, L Infanti, A Dumoulin, A Buser, J Samaridis, C Stebler, R Gosert, ... The Journal of infectious diseases 199 (6), 837-846, 2009 | 852 | 2009 |
| Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology R Gosert, CH Rinaldo, GA Funk, A Egli, E Ramos, CB Drachenberg, ... The Journal of experimental medicine 205 (4), 841-852, 2008 | 251 | 2008 |
| Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells MA Stanczak, SS Siddiqui, MP Trefny, DS Thommen, KF Boligan, ... The Journal of clinical investigation 128 (11), 4912-4923, 2018 | 234 | 2018 |
| Gut microbiota modulate T cell trafficking into human colorectal cancer E Cremonesi, V Governa, JFG Garzon, V Mele, F Amicarella, MG Muraro, ... Gut 67 (11), 1984-1994, 2018 | 230 | 2018 |
| Polyomavirus BK-specific cellular immune response to VP1 and large T-antigen in kidney transplant recipients S Binggeli, A Egli, S Schaub, I Binet, M Mayr, J Steiger, HH Hirsch American Journal of Transplantation 7 (5), 1131-1139, 2007 | 222 | 2007 |
| Comorbidities, clinical signs and symptoms, laboratory findings, imaging features, treatment strategies, and outcomes in adult and pediatric patients with COVID-19: A … CR Jutzeler, L Bourguignon, CV Weis, B Tong, C Wong, B Rieck, ... Travel medicine and infectious disease 37, 101825, 2020 | 217 | 2020 |
| The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections A Egli, DM Santer, D O’Shea, DL Tyrrell, M Houghton Emerging microbes & infections 3 (1), 1-12, 2014 | 201 | 2014 |
| Nocardia Infection in Solid Organ Transplant Recipients: A Multicenter European Case-control Study J Coussement, ... Reviews of Infectious Diseases 63 (3), 338-345, 2016 | 198 | 2016 |
| Salmonella persisters promote the spread of antibiotic resistance plasmids in the gut E Bakkeren, JS Huisman, SA Fattinger, A Hausmann, M Furter, A Egli, ... Nature 573 (7773), 276-280, 2019 | 195 | 2019 |
| Interferon lambda: modulating immunity in infectious diseases M Syedbasha, A Egli Frontiers in immunology 8, 242342, 2017 | 172 | 2017 |
| State-of-the-art monitoring of cytomegalovirus-specific cell-mediated immunity after organ transplant: a primer for the clinician A Egli, A Humar, D Kumar Clinical infectious diseases 55 (12), 1678-1689, 2012 | 169 | 2012 |
| Inhibition of polyomavirus BK-specific T-Cell responses by immunosuppressive drugs A Egli, S Köhli, M Dickenmann, HH Hirsch Transplantation 88 (10), 1161-1168, 2009 | 159 | 2009 |
| A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study TM Walker, M Merker, AM Knoblauch, P Helbling, OD Schoch, ... The Lancet Infectious Diseases 18 (4), 431-440, 2018 | 154 | 2018 |
| Cytomegalovirus and polyomavirus BK posttransplant A Egli, S Binggeli, S Bodaghi, A Dumoulin, GA Funk, N Khanna, ... Nephrology Dialysis Transplantation 22 (suppl_8), viii72-viii82, 2007 | 148 | 2007 |
| Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients A Egli, I Binet, S Binggeli, C Jäger, A Dumoulin, S Schaub, J Steiger, ... Journal of translational medicine 6, 1-12, 2008 | 139 | 2008 |
| Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events H Läubli, C Balmelli, L Kaufmann, M Stanczak, M Syedbasha, D Vogt, ... Journal for immunotherapy of cancer 6, 1-10, 2018 | 138 | 2018 |
| IL-28B is a key regulator of B-and T-cell vaccine responses against influenza A Egli, DM Santer, D O'Shea, K Barakat, M Syedbasha, M Vollmer, ... PLoS pathogens 10 (12), e1004556, 2014 | 112 | 2014 |
| Direct antimicrobial resistance prediction from clinical MALDI-TOF mass spectra using machine learning C Weis, A Cuénod, B Rieck, O Dubuis, S Graf, C Lang, M Oberle, ... Nature Medicine 28 (1), 164-174, 2022 | 97 | 2022 |
| PCR performance in the SARS-CoV-2 Omicron variant of concern? CMJA Metzger, R Lienhard, HMB Seth-Smith, T Roloff, F Wegner, ... Swiss medical weekly 151 (4950), w30120-w30120, 2021 | 91 | 2021 |
| Immunomodulatory function of interleukin 28B during primary infection with cytomegalovirus A Egli, A Levin, DM Santer, M Joyce, D O'Shea, BS Thomas, LF Lisboa, ... The Journal of infectious diseases 210 (5), 717-727, 2014 | 90 | 2014 |
Helena Seth-SmithUniversity of Zurich, Institute of Medical Microbiology在 seth-smith.org.uk 的电子邮件经过验证
